LRRK2 and Parkinson disease: Lewy bodies (LBs) and Lewy neurites (LNs) immunoreactive for α-synuclein constitute the neuropathological hallmark of iPD [9], although this finding is not universal in PD patients with the LRRK2 mutation [10].